Calgary
Currently Enrolling Studies
Upcoming
Rheumatoid Arthritis
Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderately to Severely Active Rheumatoid Arthritis
Type 2 Diabetes and Cardiovascular Risk
A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, arterial hypertension and established cardiovascular disease
Psoriatic Arthritis
A phase 3 study to investigate the efficacy and safety of subcutaneous sonelokimab in male and female participants aged 18 years and over with active psoriatic arthritis who are naive to biologic therapies
Psoriatic Arthritis
A phase 3 study with risankizumab as active reference arm, to investigate the efficacy and safety of subcutaneous sonelokimab in male and female participants aged 18 years and over with active psoriatic arthritis
Type 1 Diabetes
A randomized, double-blind, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with recently diagnosed Stage 3 Type 1 Diabetes (T1D)
Graves' Disease
An open-label Phase 2a study to investigate the efficacy of rilzabrutinib in adult participants with Graves’ disease
Future Studies
Future Studies for Men and Women in Calgary
If you would like to submit your information to be contacted for future study opportunities in Calgary, click to apply here.
